Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Prospective Validation of End-of-Treatment ctDNA-MRD by PhasED-Seq in 1L DLBCL Patients from a National Cohort
May 30, 2025 | Presentation
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
February 6, 2025 | Abstract
Clinical Trial Showcase at ASH 2024 – ALPHA3
December 18, 2024 | Presentation
Escalating Doses of AZD0486, a Novel CD19xCD3 T-cell Engager, Result in High Complete Remissions with Rapid Clearance of Minimal Residual Disease in Patients with Relapsed/Refractory Follicular Lymphoma
December 17, 2024 | Presentation
Advancing precision medicine in lymphoma with ctDNA-MRD – presentation by Dr. Mark Roschewski (NCI/NIH)
December 17, 2024 | Video
The clinical impact and cost-effectiveness of PET-based and ctDNA-based evaluation at end of therapy for frontline treatment of DLBCL
December 13, 2024 | Poster